Committee for Orphan Medicinal Products

Committee for Orphan Medicinal Products

 

Bruno Sepodes
Prof. Bruno Sepodes
COMP Chair

The Committee for Orphan Medicinal Products (COMP), headquartered in London, was created in 2000 within the European Medicines Agency (EMA) and is responsible for reviewing applications from people or companies seeking 'orphan medicinal product designation'.

Activities and role

The COMP is also responsible for advising the European Commission on the establishment and development of a policy on orphan medicinal products in the EU, and assists the Commission in drawing up detailed guidelines and liaising internationally on matters relating to orphan medicinal products.

The COMP is composed of:

  • a chairperson, elected by serving COMP members;
  • one member nominated by each of the 27 EU Member States;
  • three members nominated by the European Commission to represent patients' organisations;
  • three members nominated by the European Commission on the EMA's recommendation;
  • one member nominated by each of the EEA-EFTA states (Iceland, Liechtenstein and Norway);
  • one European Commission representative;
  • general observers.

See COMP members for the list of current members.

EURORDIS representation at COMP:

In addition to voting members, a number of Observers attend COMP meetings, including two EURORDIS representatives.

Lesley Greene

Mrs. Lesley Greene,
Vice-chair of COMP

EURORDIS nominated Patient Representative
Current mandate: July 2012 – 2015

Mrs. Birthe Byskov Holm,
EURORDIS nominated Patient Representative

Current mandate: July 2012 – 2015
Danish Osteogenesis Imperfecta Association

 
 

Dr. Maria Mavris, EURORDIS Observer

 

For further information:

Committee for Orphan Medicinal Products (COMP) Scientific Advice and Orphan Drugs Pre-authorisation Evaluation of Medicines for Human Use
7 Westferry Circus Canary Wharf London E14 4 HB United Kingdom
Tel: + (44-20) 74 18 84 00 Fax: + (44-20) 75 23 70 40 e-mail: info@ema.europa.eu
More information at www.ema.europe.eu.

 

Photos & graphics: © EMA

Page created: 19/08/2009
Page last updated: 08/09/2012
 
 
The voice of rare disease patients in EuropeEURORDIS Bringing together patients, families and experts to share experiences in a moderated multilanguage forum, RareConnect is a EURORDIS initiative RareConnect An international awareness raising campaign taking place on the last day of February each year, Rare Disease Day is a EURORDIS initiativeRare Disease Day Join the largest gathering of rare disease stakeholders across Europe, at the biennial European Conference on Rare Diseases and Orphan Products. ECRD is a EURORDIS initiativeEuropean Conference on Rare Diseases